Zobrazeno 1 - 10
of 39
pro vyhledávání: ''
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8483-8496 (2021)
Cancer Medicine
Cancer Medicine
Background The optimal treatment for elderly patients with esophageal cancer (EC) remains controversial. In the present study, we aimed to investigate whether elderly patients with stage II–III EC could benefit from trimodal therapy. Methods The se
Autor:
David Liska, Smitha S. Krishnamurthi, Alok A. Khorana, Kanika G. Nair, Nataly Valeria Torrejon, Suneel Deepak Kamath, Katherine Tullio, Wei Wei
Publikováno v:
Cancer Medicine, Vol 10, Iss 21, Pp 7542-7550 (2021)
Cancer Medicine
Cancer Medicine
Background The incidence of colorectal cancer (CRC) in patients under age 50 is rising for unclear reasons. We examined the effects of socioeconomic factors on outcomes for patients with early‐onset CRC compared to late‐onset CRC. Methods Patient
Publikováno v:
Cancer Medicine, Vol 10, Iss 20, Pp 7330-7338 (2021)
Cancer Medicine
Cancer Medicine
Background Racial/ethnic disparities in the utilization of hematopoietic cell transplantation (HCT) have been reported for patients with hematologic malignancies, but population‐based data are lacking for lymphoma patients. The objective of this st
Autor:
Rajesh Balkrishnan, Aditya Narayan, Lucas E Flausino, Raj P Desai, Roger Chammas, Fabian Camacho
Publikováno v:
Cancer Medicine, Vol 10, Iss 15, Pp 5347-5357 (2021)
Cancer Medicine
Cancer Medicine
Purpose Colorectal cancer (CRC) diagnosis is associated with high mortality in the United States and thus warrants the study of novel treatment approaches. Vascular changes are well observed in cancers and evidence indicates that antihypertensive (AH
Autor:
Caitlin C. Murphy, Danyi Xiong, Bhumika Maddineni, Ethan A. Halm, David E. Gerber, Sandi L. Pruitt, Hong Zhu, Daniel F. Heitjan, Anna Tavakkoli, Amit G. Singal
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 14, Pp 4752-4767 (2021)
Cancer Medicine, Vol 10, Iss 14, Pp 4752-4767 (2021)
Patients with previous cancer are often excluded from clinical trials despite limited evidence about their prognosis. We examined the effect of previous cancer on overall and colorectal cancer (CRC)‐specific survival of patients newly diagnosed wit
Autor:
Yanmei Qin, Cheng Yang, Zhihua Hu, Sha Tao, Rentao Zhang, Changming Lin, Zhengquan Wang, Yuan Zhou, Yinman Ding
Publikováno v:
Cancer Medicine
Background Although the latest Gleason grading system in 2014 has distinguished between Gleason 3 + 4 and 4 + 3, Gleason 8 and Gleason 9–10 are remained systemically classified. Methods A total of 261,125 patients diagnosed with prostate cancer (PC
Publikováno v:
Cancer Medicine
Purpose To establish a prognostic model to estimate the cancer‐specific survival (CSS) for urothelial carcinoma of bladder (UCB) patients after radical cystectomy (RC). Methods A total of 8650 candidates (2004–2011) obtained from the Surveillance
Publikováno v:
Cancer Medicine
Background Low‐grade gangliogliomas (GGs) are rare tumors of the central nervous system in adults. This study aims to define their characteristics, prognostic factors, and the impact of different treatment patterns on survival. Methods The Surveill
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 21, Pp 7988-8003 (2020)
Cancer Medicine, Vol 9, Iss 21, Pp 7988-8003 (2020)
Objective To compare the survival outcomes of local ablation (LA) and partial nephrectomy (PN) for T1N0M0 renal cell carcinoma (RCC). Method We identified 38,155 T1N0M0 RCC patients treated with PN or LA in 2004‐2016 from the retrospective Surveill
Publikováno v:
Cancer Medicine
Cancer medicine, vol 9, iss 22
Cancer Medicine, Vol 9, Iss 22, Pp 8310-8317 (2020)
Cancer medicine, vol 9, iss 22
Cancer Medicine, Vol 9, Iss 22, Pp 8310-8317 (2020)
Background Black individuals with muscle‐invasive bladder cancer (MIBC) experienced 21% lower odds of guideline‐based treatment (GBT) and differences in treatment explain 35% of observed Black‐White differences in survival. Yet little is known